Viewing Study NCT02649361


Ignite Creation Date: 2025-12-24 @ 11:58 AM
Ignite Modification Date: 2026-01-10 @ 4:47 AM
Study NCT ID: NCT02649361
Status: COMPLETED
Last Update Posted: 2019-06-05
First Post: 2016-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module